MedPath

JUBAAN LTD

๐Ÿ‡ฎ๐Ÿ‡ฑIsrael
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal Cancer

Not Applicable
Not yet recruiting
Conditions
Colorectal Cancer
Colorectal Adenomatous Polyp
Colorectal Neoplasms
First Posted Date
2024-11-14
Last Posted Date
2024-11-14
Lead Sponsor
Jubaan Ltd.
Target Recruit Count
800
Registration Number
NCT06688110
Locations
๐Ÿ‡ณ๐Ÿ‡ฑ

Erasmus MC, Rotterdam, Netherlands

Evaluation of Gixam's Performance in a FIT Negative Population

Phase 2
Recruiting
Conditions
Colorectal Adenoma
Colorectal Cancer (CRC)
Colorectal Cancer (CRC) Screening
Interventions
Device: colorectal cancer (CRC) screening
Diagnostic Test: colorectal cancer screening
Procedure: Colonoscopy after bowel cleansing
First Posted Date
2024-09-25
Last Posted Date
2024-11-14
Lead Sponsor
Jubaan Ltd.
Target Recruit Count
400
Registration Number
NCT06612281
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Oregon Clinic Gastroenterology-East, Portland, Oregon, United States

Predicting Adenomatous Polyps in the Colon Using Images of a Human Tongue

Not Applicable
Completed
Conditions
Gastrointestinal Microbiome
Colorectal Neoplasms
Interventions
Device: Gixam
First Posted Date
2024-03-12
Last Posted Date
2025-02-20
Lead Sponsor
Jubaan Ltd.
Target Recruit Count
426
Registration Number
NCT06305364
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NYU Langone Health, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Westside GI, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

NewYork-Presbyterian / Columbia University Irving Medical Center, New York, New York, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath